Pharmacia Takes Steps to Provide HIV Drug in Poor Countries
By Biotechdaily staff writers
Posted on 07 Feb 2003
During the World Economic Forum in Davos (Switzerland), Pharmacia Corp. (Peapack, NJ, USA) announced the launch of a pilot program for expanding access to needed medicines for the poorest populations in the developing world.Posted on 07 Feb 2003
Under the program, Pharmacia will grant nonexclusive licenses for delavirdine, a medicine for HIV/AIDS, to generic pharmaceutical companies that agree to make and supply the product to the world's poorest countries. Delavirdine is among the antiretroviral therapies recommended by the US Department of Health and Human Services for treatment of HIV/AIDS.
Pharmacia will transfer its proprietary manufacturing technology and regulatory dossier for delavirdine to the International Dispensary Association Foundation (IDA, Amsterdam, The Netherlands), which can select any generic companies that meet its manufacturing standards to make the drug. IDA is the world's largest nonprofit supplier of generic medicines to developing countries and relief agencies.
"This is an innovative approach to the complex access issue that we believe deserves to be tested in real world conditions,” said Fred Hassan, chairman and CEO of Pharmacia.
Related Links:
Pharmacia
International Dispensary Association Foundation
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Aspiration System
VACUSAFE
New
HPV Test
Allplex HPV28 Detection
New
Automatic CLIA Analyzer
Shine i6000
